A randomized trial of cyclophosphamide, doxorubicin, and cisplatin with or without bacillus Calmette-Guerin in patients with suboptimal stage III and IV ovarian cancer: a Gynecologic Oncology Group study.

A randomized trial of cyclophosphamide, doxorubicin, and cisplatin with or without bacillus Calmette-Guerin in patients with suboptimal stage III and IV ovarian cancer: a Gynecologic Oncology Group study. Gynecol Oncol. 1990 Dec; 39(3):239-43.

View in: PubMed

subject areas

Antineoplastic Combined Chemotherapy Protocols
BCG Vaccine
Cisplatin
Cyclophosphamide
Doxorubicin
Female
Humans
Middle Aged
Neoplasm Staging
Ovarian Neoplasms
Survival Analysis

authors with profiles

William Thomas Creasman